Pharmaceutical Product Development, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

More than 10.000 documents for Pharmaceutical Product Development, Inc.

- Research and Markets: Pharmaceutical Product Development Inc - Therapeutic Competitors.
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/dc413f/pharmaceutical_pro) has announced the addition of the "Pharmaceutica...
- Business Wire
- June 21, 2010
- Law Offices of Howard G. Smith LLP Continues Investigation of Pharmaceutical Product Development, Inc.
LOS ANGELES -- Law Offices of Howard G. Smithis continuing its investigation of potential claims against the Board of Directors of Pharmaceutical Prod...
- Business Wire
- October 07, 2011
- S&P Indices Announces Changes to U.S. Indices
NEW YORK, Dec. 5, 2011 /PRNewswire/ -- S&P SmallCap 600 constituent National Retail Properties Inc. (NYSE: NNN) will replace Pharmaceutical Product Development Inc. (NASD: PPDI) in the S&P MidCap 400 index, and Higher One Holdings Inc. (NYSE: ONE) will replace National Retail Properties in the S&P SmallCap 600 index after the close of trading on Wednesday, December 7. Pharmaceutical Product Development is being acquired by affiliates of The Carlyle Group and Hellman & Friedman in a deal that closed today. S&P Indices will post any relevant updates on its website: www.standardandpoors.com.
- U.S. Newswire
- December 06, 2011

- Zacks.com Announces That Dr. Edward Olmstead Highlights Options for the Following Stocks: Pharmaceutical Product Development Inc and YUM! Brands Inc.
CHICAGO -- Dr. Edward Olmstead and his team, from the Options Professor newsletter, offer two call positions. Learn about Pharmaceutical Product Devel...
- Business Wire
- May 22, 2006
- Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
...The listing for each transaction includes the transaction number and the parties to the tran... G Teva Pharmaceuticals. Indus... G Complete Production Services,. ... Development, Inc.; Carlyle. ...
- Federal Register Nbr. 76 FR 70452, November 14, 2011
- Notices
- Federal Trade Commission
- Mintz Levin Attorney works on international deal: San Diego-based attorney Jeremy Glaser, who practices corporate law at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo RC., recently represented contract research organization BioDuro LLC in its acquisition by Pharmaceutical Product Development Inc.
Mintz Levin Attorney Works On International Deal: San Diego-based attorney Jeremy Glaser, who practices corporate law at Mintz, Levin, Cohn, Ferris, G...
- San Diego Business Journal
- January 25, 2010
- Pharmaceutical Product Development, Inc. names new president/COO, completes international acquisitions.
WILMINGTON, N.C.--(HealthWire)--Nov. 11, 1996--Pharmaceutical Product Development, Inc. (PPD) has named Thomas D'Alonzo, 52, as its new president and ...
- Business Wire
- November 11, 1996
- Sex drug and rocky road ahead for research firm.
Pharmaceutical Product Development Inc. - Brief Article
- Business North Carolina
- Vol. 19 Nbr. 11, November 1999
- The Daily Record Business Briefs: June 23, 2011
China connection Sirnaomics Inc. of Gaithersburg, a drug development company focused on wound healing, diabetic therapeutics, antiviral therapies, oncology therapeutics and others, said it has signed a partnership agreement with Guangdong Zhongsheng Pharmaceutical Co. Ltd., a publicly traded Chinese pharmaceutical company. The partnership will focus on development and commercialization of STP601, Sirnaomics' therapeutic product candidate to treat diabetic retinopathy and age-related macular degeneration. Guangdong Zhongsheng is committing $9.75 million to the relationship, including upfront and milestone payments, royalty sharing and a market-sharing arrangement with Sirnaomics.
- The Daily Record (Baltimore)
- June 30, 2011
- Collegium Pharmaceutical Inc. and United Research Laboratories/Mutual Pharmaceutical Company Announce Product Development Agreement.
CUMBERLAND, R.I. -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical product development company, and URL/Mutual Pharmaceutical Company, a p...
- Business Wire
- April 20, 2005